(Q50857490)

English

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

scientific article

Statements

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit